<h4>Background</h4>Parenteral polymyxin use declined after the 1960s, due to safety concerns. An increase in multidrug-resistant (MDR) gram-negative infections and a shortage of new agents have prompted increased use of parenteral polymyxin.<h4>Objective</h4>To describe our clinical experience with ...
No comments yet
Be the first to share your thoughts!